Literature DB >> 12530973

Syndecan captures, protects, and transmits HIV to T lymphocytes.

Michael D Bobardt1, Andrew C S Saphire, Hsiu-Cheng Hung, Xiaocong Yu, Bernadette Van der Schueren, Zhe Zhang, Guido David, Philippe A Gallay.   

Abstract

This study demonstrates that syndecan functions as an in trans HIV receptor. We show that syndecan, when expressed in nonpermissive cells, becomes the major mediator for HIV adsorption. This adsorption is mediated by the binding of gp120 to the heparan sulfate chains of syndecan. Although syndecan does not substitute for HIV entry receptors, it enhances the in trans infectivity of a broad range of primate lentiviruses including primary viruses produced from PBMCs. Furthermore, syndecan preserves virus infectivity for a week, whereas unbound virus loses its infectivity in less than a day. Moreover, we obtain evidence suggesting that the vast syndecan-rich endothelial lining of the vasculature can provide a microenvironment which boosts HIV replication in T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12530973     DOI: 10.1016/s1074-7613(02)00504-6

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  87 in total

1.  Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Authors:  Juan Sabatté; Jorge Geffner; Ezequiel Dantas; Fernando Erra Díaz; Pehuén Pereyra Gerber; Augusto Varese; Diana Alicia Jerusalinsky; Alberto L Epstein; Hernán J García Rivello; Ana Del Valle Jaén; Julieta B Pandolfi; Ana Ceballos; Matias Ostrowski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  Advances in our understanding of the pathogenesis of HIV-1 associated nephropathy in children.

Authors:  Patricio E Ray; Chien-An A Hu
Journal:  Future Virol       Date:  2011-07       Impact factor: 1.831

Review 3.  Dangerous liaisons at the virological synapse.

Authors:  Vincent Piguet; Quentin Sattentau
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

4.  Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.

Authors:  Nadine Jarousse; Damian L Trujillo; Sarah Wilcox-Adelman; Laurent Coscoy
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

Review 5.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

6.  HIV-1 N-glycan composition governs a balance between dendritic cell-mediated viral transmission and antigen presentation.

Authors:  Thijs van Montfort; Dirk Eggink; Maikel Boot; Michael Tuen; Catarina E Hioe; Ben Berkhout; Rogier W Sanders
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

7.  Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.

Authors:  Timothy D Culp; Lynn R Budgeon; M Peter Marinkovich; Guerrino Meneguzzi; Neil D Christensen
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates.

Authors:  Abraham Pinter; William J Honnen; Paul D'Agostino; Miroslaw K Gorny; Susan Zolla-Pazner; Samuel C Kayman
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

Review 10.  HIV infection of the genital mucosa in women.

Authors:  Florian Hladik; Thomas J Hope
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.